이오플로우
294090KOSDAQ57.5 / 100
Reference Date: 2026-10-23
Company InformationBased on 2025 Annual Report
Business Overview
EoFlow is a medical device company established in 2011, specializing in wearable insulin pumps using electroosmotic pump technology. It launched the disposable wearable insulin pump EOPatch in 2021, which offers superior convenience, waterproofing, and longer replacement intervals compared to existing products, securing a competitive edge in the diabetes medical device market. The company expanded into European markets in 2022 and is exploring diverse fields such as obesity and NASH treatments through non-insulin pump business. However, its non-insulin business has been halted due to a lawsuit with Insulet.
Number of Employees
51people
Average Salary
55.0M KRW
Score Calculation Basis
Detailed Financial Score
Half of industry avg (excellent)
Avg ▼25.4% (2-year basis)
Avg ▲4.3% (2-year basis)
Avg ROE -140.2% (declining, 2yr)
Detailed News Sentiment
Detailed Momentum
52w mid range (50%)
1m 0% (flat)
Volume flat
Detailed Disclosure
- Neutral기타시장안내(최대주주의의무보유관련) (최대주주의 의무보유 이행 관련)2026-10-22
- Negative소송등의판결ㆍ결정(일정금액이상의청구) (영업비밀보호법(“DTSA”)에 따른 영업비밀 침해 및 특허 침해 소송)2026-10-20
- Neutral주요사항보고서(전환사채권발행결정)2026-10-15
- Neutral주요사항보고서(자본으로인정되는채무증권발행결정)2026-10-15
- Positive[기재정정]주요사항보고서(유상증자결정)2026-10-12
